William Gray, MD
Interventional Cardiology · Wynnewood, PANPI 1720165640
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $524,026 of the $753,303 with a category attached, or 69.6%. 39 manufacturers reported payments, led by Philips North America LLC at 26.6% of the total. Among interventional cardiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,020 payments — averaging $738.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$200K
- W. L. Gore & Associates, Inc.$136K
- Boston Scientific$109K
- Shockwave Medical, Inc$81K
- Medtronic$69K
- Edwards Lifesciences$38K
- plus $121K from 33 others
Across 400 payments — averaging $7003.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$2.1M
- Contego Medical, Inc$270K
- Medtronic$162K
- Boston Scientific$105K
- Abbott$59K
- Surmodics, Inc.$25K
- plus $56K from 5 others
Across 4 payments — averaging $532.50 each. An ownership or investment interest held by the physician or an immediate family member.
- Reflow Medical Inc$2K
- Contego Medical, Inc$0
What the payments were for
- Consulting fees$524,02670%
- Speaking & faculty fees$84,76211%
- Travel & lodging$87,30012%
- Food & beverage$30,5154%
- Ownership interest$26,7004%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 129 | $200,003 |
| W. L. Gore & Associates, Inc. | 88 | $136,206 |
| Boston Scientific | 328 | $108,783 |
| Shockwave Medical, Inc | 23 | $80,783 |
| Medtronic(2 entities) | 191 | $69,110 |
| Edwards Lifesciences | 137 | $37,534 |
| Surmodics, Inc. | 11 | $28,199 |
| Contego Medical, Inc | 2 | $26,857 |
| Intact Vascular, Inc. | 13 | $24,072 |
| Baylis Medical Company Inc | 7 | $8,694 |
| Penumbra, Inc. | 2 | $8,400 |
| Cordis US CORP. | 6 | $8,217 |
| Cagent Vascular Inc | 4 | $5,284 |
| Endologix LLC | 8 | $4,068 |
| Abbott | 23 | $4,050 |
| Inspiremd Ltd | 6 | $854 |
| Siemens Medical Solutions USA, Inc. | 7 | $649 |
| Mercator Medsystems, Inc. | 1 | $271 |
| Heartflow, Inc. | 3 | $209 |
| AbbVie | 2 | $207 |
| Centerline Biomedical Inc. | 3 | $125 |
| Devoro Medical Inc. | 1 | $104 |
| Johnson & Johnson | 1 | $100 |
| E.r. Squibb & Sons, L.L.C. | 3 | $77 |
| Novo Nordisk | 2 | $54 |
| Cardiovascular Systems Inc. | 2 | $52 |
| Acist Medical Systems, Inc. | 1 | $43 |
| Pfizer | 3 | $40 |
| Getinge USA Sales, LLC | 2 | $39 |
| Imperative Care, Inc | 1 | $35 |
| Vesper Medical | 1 | $33 |
| Abiomed | 1 | $27 |
| AstraZeneca | 2 | $23 |
| Boehringer Ingelheim | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $20 |
| Terumo Medical Corporation | 1 | $17 |
| Teleflex LLC | 1 | $16 |
| Biosense Webster, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$171,418
- Product in Development$86,412
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$41,750
- GORE VIABAHN Endoprosthesis with Heparin$39,028
- Vascular Lithotripsy$39,000
- VIATORR Endoprosthesis$38,860
- GORE PROPATEN Vascular Graft$35,008
- GENERAL - THERAPIES$27,455
- SurVeil$26,975
- VersaCross Access Solution$26,091
- Tack Endovascular System$24,000
- IN.PACT Admiral$23,309
- GORE VIABAHN Endoprosthesis$23,053
- GORE-TEX Vascular Graft$19,305
- GORE-TEX Stretch Vascular Graft$16,248
- GORE ACUSEAL Vascular Graft$16,248
- Spectranetics Undiv$13,636
- (6554) Peripheral Vascular Undivided$11,168
- GORE VIABAHN VBX Balloon Expandable Endo$10,733
- AngioJet Ultra 5000A$10,625
How this compares
$753,303 in reported general payments places this provider in the 95th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 17 | $237 |
| Amlodipine Besylate | 21 | $165 |
| Rosuvastatin Calcium | 11 | $141 |
| Losartan Potassium | 13 | $110 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $50 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Wynnewood
- Eric GnallWynnewood$183K
- Timothy ShapiroWynnewood$96K
- Hamza HafeezWynnewood$32K
- David BarryWynnewood$26K
- Nishant SethiScranton$1.3M
- Matthew BeckerErie$1M
- Jon GeorgePhiladelphia$637K
- Shailendra SinghAllentown$470K
- Sanjog KalraPhiladelphia$444K
- James HarveyChambersburg$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.